BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 33448579)

  • 1. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
    Campbell LA; Richie CT; Maggirwar NS; Harvey BK
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
    Camperi J; Moshref M; Dai L; Lee HY
    Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
    Lyu P; Javidi-Parsijani P; Atala A; Lu B
    Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes.
    Wang Y; Wang B; Xie H; Ren Q; Liu X; Li F; Lv X; He X; Cheng C; Deng R; Li J; Zhao J; Song Z; Gu F
    Biotechnol J; 2019 Jul; 14(7):e1800689. PubMed ID: 30927491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
    Chen X; Chen Y; Xin H; Wan T; Ping Y
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing noncanonical crRNA for highly efficient genome editing.
    Xun G; Zhu Z; Singh N; Lu J; Jain PK; Zhao H
    Nat Commun; 2024 May; 15(1):3823. PubMed ID: 38714643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System.
    Aksoy YA; Yang B; Chen W; Hung T; Kuchel RP; Zammit NW; Grey ST; Goldys EM; Deng W
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52433-52444. PubMed ID: 33174413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
    Kim H; Choi J; Won KH
    BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment.
    Kim SM; Shin SC; Kim EE; Kim SH; Park K; Oh SJ; Jang M
    ACS Nano; 2018 Aug; 12(8):7750-7760. PubMed ID: 30028587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
    Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
    Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang.
    Bin Moon S; Lee JM; Kang JG; Lee NE; Ha DI; Kim DY; Kim SH; Yoo K; Kim D; Ko JH; Kim YS
    Nat Commun; 2018 Sep; 9(1):3651. PubMed ID: 30194297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key sequence features of CRISPR RNA for dual-guide CRISPR-Cas9 ribonucleoprotein complexes assembled with wild-type or HiFi Cas9.
    Okada K; Aoki K; Tabei T; Sugio K; Imai K; Bonkohara Y; Kamachi Y
    Nucleic Acids Res; 2022 Mar; 50(5):2854-2871. PubMed ID: 35166844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles.
    Semikolenova O; Sakovina L; Akhmetova E; Kim D; Vokhtantsev I; Golyshev V; Vorobyeva M; Novopashin S; Novopashina D
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
    Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
    Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
    Wang R; Graham S; Gao L; Tam J; Levesque MC
    Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing.
    Mun D; Kang JY; Kim H; Yun N; Joung B
    J Control Release; 2024 Jun; 370():798-810. PubMed ID: 38754633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.